Financials Crystalvue Medical Corporation

Equities

6527

TW0006527005

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 23:00:00 29/04/2024 BST 5-day change 1st Jan Change
78.2 TWD -.--% Intraday chart for Crystalvue Medical Corporation +0.90% -9.80%

Valuation

Fiscal Period: December 2019 2022 2023 2024
Capitalization 1 1,681 1,241 2,190 1,976
Enterprise Value (EV) 1 1,681 1,241 2,190 1,976
P/E ratio 18.6 x 11 x 21.2 x 14.5 x
Yield - - - -
Capitalization / Revenue 2.54 x - 2.66 x 2.06 x
EV / Revenue 2.54 x - 2.66 x 2.06 x
EV / EBITDA - - - -
EV / FCF - - 14.6 x 30.9 x
FCF Yield - - 6.83% 3.24%
Price to Book - - 2.56 x -
Nbr of stocks (in thousands) 22,491 25,057 25,264 25,264
Reference price 2 74.76 49.52 86.70 78.20
Announcement Date 29/03/20 24/02/23 01/03/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2022 2023 2024
Net sales 1 661.1 - 824 961
EBITDA - - - -
EBIT 1 114.1 - 117.7 170
Operating Margin 17.25% - 14.28% 17.69%
Earnings before Tax (EBT) 1 111.7 - 119.7 170
Net income 1 91.08 115 103.2 138
Net margin 13.78% - 12.53% 14.36%
EPS 2 4.019 4.514 4.090 5.410
Free Cash Flow 1 - - 149.6 64
FCF margin - - 18.16% 6.66%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - 145% 46.38%
Dividend per Share - - - -
Announcement Date 29/03/20 24/02/23 01/03/24 -
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2023 Q2 2023 Q3 2023 Q4
Net sales 1 327.7 - 220 189.4
EBITDA - - - -
EBIT 1 52.8 - 24.24 31.17
Operating Margin 16.11% - 11.02% 16.45%
Earnings before Tax (EBT) 1 47.99 - 29.14 25.97
Net income 1 42.56 34.47 23.31 18.39
Net margin 12.99% - 10.6% 9.71%
EPS 2 1.876 1.380 0.9300 0.7100
Dividend per Share - - - -
Announcement Date 29/03/20 14/08/23 14/11/23 01/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2022 2023 2024
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 - - 150 64
ROE (net income / shareholders' equity) - - 12.7% 15.6%
ROA (Net income/ Total Assets) - - 9.89% 12.2%
Assets 1 - - 1,044 1,131
Book Value Per Share - - 33.90 -
Cash Flow per Share - - - -
Capex 1 - - 4.37 50
Capex / Sales - - 0.53% 5.2%
Announcement Date 29/03/20 24/02/23 01/03/24 -
1TWD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
78.2 TWD
Average target price
92 TWD
Spread / Average Target
+17.65%
Consensus
  1. Stock Market
  2. Equities
  3. 6527 Stock
  4. Financials Crystalvue Medical Corporation